WO2025083627 - NOVEL CRYSTALLINE FORMS OF MITAPIVAT SULFATE AND PROCESSES FOR PREPARATION

National phase entry is expected:
Publication Number WO/2025/083627
Publication Date 24.04.2025
International Application No. PCT/IB2024/060258
International Filing Date 18.10.2024
Title [English] NOVEL CRYSTALLINE FORMS OF MITAPIVAT SULFATE AND PROCESSES FOR PREPARATION [French] NOUVELLES FORMES CRISTALLINES DE SULFATE DE MITAPIVAT ET PROCÉDÉS DE PRÉPARATION ASSOCIÉS
Applicants ** APITORIA PHARMA PRIVATE LIMITED Galaxy, Floors: 22-24, Plot No. 1, Survey No. 83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Telangana. Hyderabad 500 032, IN
Inventors ** KOREPU, Padma Apitoria Pharma Private Limited, Galaxy, Floors: 22-24, Plot No. 1, Survey No. 83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Telangana Hyderabad 500 032, IN MUPPALLA, Siva Rama Krishna Apitoria Pharma Private Limited, Galaxy, Floors: 22-24, Plot No. 1, Survey No. 83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Telangana Hyderabad 500 032, IN NASIR, Ali Apitoria Pharma Private Limited, Galaxy, Floors: 22-24, Plot No. 1, Survey No. 83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Telangana Hyderabad 500032, IN NEELA, Praveen Kumar Apitoria Pharma Private Limited, Galaxy, Floors: 22-24, Plot No. 1, Survey No. 83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Telangana Hyderabad 500032, IN
Priority Data 202341071009  18.10.2023  IN
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 922
EPO Filing, Examination 6380
Japan Filing 565
South Korea Filing 578
USA Filing, Examination 3235
MasterCard Visa
Total: 11680
Abstract [English] The present invention relates to novel polymorphs of Mitapivat sulfate, designated as crystalline Mitapivat sulfate Form MIP-1 and MIP-2 and processes for the preparation thereof. [French] La présente invention concerne de nouveaux polymorphes de sulfate de mitapivat, désignés en tant que formes cristallines de sulfate de mitapivat MIP-1 et MIP-2, et leurs procédés de préparation.